The US Food and Drug Administration should immediately ban third-generation oral contraceptives containing desogestrel because they almost double the risk of life-threatening blood clots compared to older forms of birth control pills, the US consumer group Public Citizen has said in a petition filed on February 6.
It is estimated that American women filled more than 7.5 million prescriptions for third-generation OCs from November 2005 to October 2006. Banning the pills, says Public Citizen, could save hundreds of women a year from developing venous thrombosis, which have disabling and sometimes fatal consequences.
Opens dialog on safe birth control
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze